Gambia vs Tunisia: Access to anti-retroviral drugs, male
Gambia
27.0%
in 2024
Tunisia
28.0%
in 2024
Gambia rank
136th
Tunisia rank
133rd
Access to anti-retroviral drugs, male over time
- Gambia
- Tunisia
How they compare
Tunisia currently reports 28.0% against 27.0% in Gambia, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Tunisia ahead.
Gambia ranks 136th and Tunisia ranks 133rd of 141 countries.
Across the 3 decades both report, Gambia averaged higher in 2 and Tunisia in 1.
Head to head by decade
| Decade | Gambia | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.4% | 3.7% | 2.3% | Tunisia |
| 2010s | 12.2% | 10.5% | 1.7% | Gambia |
| 2020s | 22.2% | 22.0% | 0.2% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Gambia or Tunisia?
- Tunisia, at 28.0% against 27.0% in Gambia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Gambia and Tunisia?
- 1.0%, with Tunisia ahead.
- How many years of comparable data are there for Gambia and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Gambia and Tunisia rank globally for access to anti-retroviral drugs, male?
- Gambia ranks 136th and Tunisia ranks 133rd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.